Enhanced Inhibition of Hepatocellular Carcinoma
Investigating the combined use of Tan I and EADM in Hepatocellular Carcinoma and the underlying mechanism of PI3K/AKT/HIF-1α
United States Vigene Biosciences Laboratory Animals Combination Of Two Drugs Group National Institutes Of Health Cancer Center
Source: dovepress.com